Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: A randomized study of amoxicillin-clavulanate and ceftriaxone

Microbial Drug Resistance

Volumn 7, Issue 1, 2001, Pages 85-96

  Roson B ^a   Carratala J ^a   Tubau, F ^a   Dorca, J ^a   Linares J ^a   Pallares, R ^a   Manresa, F ^a   Gudiol, F ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 0035067325     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/107662901750152864     Document Type: Article

References (38)

1. Community-acquired pneumonia in adults: Guidelines for management. The Infectious Disease Society of America
2. Community-acquired pneumonia
3. Community-acquired pneumonia
4. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
5. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae
6. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program
7. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases
8. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996)
9. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989
10. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacion versus ceftriaxone and/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia
11. A prediction rule to identify low-risk patients with community-acquired pneumonia
12. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis
13. Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia
14. Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia
15. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II
16. Management of community-acquired pneumonia in the era of pneumococcal resistance. A report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group
17. Expanding uses of fluoroquinolones: Opportunities and challenges
18. Management of infections due to antibiotic-resistant Streptococcus pneumoniae
19. A simplified acute physiology score for ICU patients
20. Fluoroquinolone resistance in Streptococcus pneumoniae
21. Antibiotic resistance in Streptococcus pneumoniae in Spain: An overview of the 1990s
22. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics
23. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990)
24. Molecular epidemiology of penicillin-resistant isolates recovered in Italy from 1993 to 1996
25. Community-acquired pneumonia requiring hospitalization: 5-year prospective study
26. Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery
27. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
28. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin resistant pneumococci
29. Impact of antibiotic resistance on chemotherapy for pneumococcal infections
30. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci
31. Distribution of capular types and penicillin resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age
32. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection
33. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin non-susceptible Streptococcus pneumoniae
34. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group
35. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases